Connecting the safety of PN ordering with an IV workflow management system delivers improvements in compounding safety by removing the human element from the process. Formulas are verified prior to compounding, orders are transmitted electronically, and pump results are recorded in the IVWM system.
In this webinar, Andy Teel, Pharmacy Systems Analyst at University of New Mexico Hospitals (UNMH) and Robert (RC) Hellinga, Pediatric Clinical Lead Pharmacist at UNMH, will discuss the advantages of building and implementing an IV workflow system to increase the safety of PN administration.
The value of clearly established SOPs that are consistently reflected in the department’s actual practices cannot be overstated. In this webinar, Patti Kienle, director of accreditation and medication safety at Cardinal Health, will review strategies, resources, and steps to avoid common mistakes with SOPs, with an eye toward USP compliance.
Staying current with USP regulations is an essential pharmacy responsibility. In this webinar, based on PP&P’s State of Pharmacy Compounding survey data for 2022, Fred Massoomi and Deanne Halvorsen will review changing regulatory requirements, recent inspection focal points, and the current state of compliance to USP <797> by hospitals nationwide.
A successful IV workflow system implementation for parenteral compounding requires the incorporation of several key factors including:
USP <800> requires the use of CSTDs for drug administration and recommends the use of CSTDs where possible for drug preparation. While most pharmacies have implemented CSTDs in the pharmacy, usage on the units is not as consistent, leaving facilities at risk for regulatory actions. In this webinar, Fred Massoomi and Seth Eisenberg will review opportunities to ensure appropriate CSTD adoptions throughout the facility.
Identifying and interpreting enforcement trends inside the regulatory actions for 503B outsourced compounders can assist health care facilities in choosing appropriate 503B partners. Furthermore, an understanding of the FDA’s current focus can help hospital and health system pharmacies monitor their outsourcing partners while improving their own compounding programs. Utilizing the largest independent database of FDA compounding activities and documents outside of the FDA itself, Lou Diorio, RPh, FAPhA, of LDT Health Solutions will analyze the long-term trends and current developments in FDA inspections of 503B compounders.
In this webinar, Scott Soefje, director of pharmacy cancer care services at the Mayo Clinic, will review challenges pharmacy faces in preparing hazardous drugs. Attendees will learn how CSTDs can be used to overcome these challenges, increase workflow efficiency, and help enhance safety and compliance.
With the COVID-19 pandemic, pharmacy continues to manage new challenges in medication handling, including risks related to product selection, preparation, and administration. In this webinar, Huda Cotta-Dethlefs, PharmD, will explore how to improve communication among all members of the health care team under today’s circumstances and beyond for safer patient outcomes. The presentation will explore solutions to some of the clinical and practical challenges in medication handling, with a focus on compounding and medication crushing, as well as unit dose purchasing options.
Pharmacies face challenges in training technicians to demonstrate competence and compliance, especially regarding USP <800> guidelines. In this webinar, Abby Roth will provide strategies that pharmacists can use to maximize the capabilities of a fully trained technician support system.
Maintaining a state of control is essential in the cleanroom. In this webinar, Patti Kienle will review updates to USP standards, clarify environmental monitoring guidelines, detail how to conduct air and surface sampling, and identify locations for HD wipe sampling.
The process of diversion prevention can begin with strategies to eliminate medication tampering. In this webinar, Kimberly New, JD, BSN, RN, will illustrate how to provide a foundation for success by implementing security measures that prevent tampering. Further, attendees will learn how to ensure continuous practice improvement via structured reporting and scheduled audits.
Protecting health care personnel from HD exposure is an essential pharmacy responsibility, and USP <800> establishes guidelines to mitigate this risk. In this webinar, based on PP&P’s most recent survey data, Fred Massoomi and Deanne Halvorsen will review regulatory requirements, recent inspection focal points, and the current state of compliance to USP <800> by hospitals nationwide.
Even with a compliant environmental monitoring program and a robust cleaning regimen, pharmacy is subject to contamination events in the cleanroom. In this webinar, Jim Wagner will discuss how to identify and mitigate potential points of contamination.
PECs are active all day, every day, for years at a time. As such, they must be maintained on an ongoing basis. In this webinar, Fred Massoomi, PharmD, FASHP, will discuss the types of maintenance necessary for different PECs, how to determine the lifespan of the PEC, and ways to ensure adherence to maintenance expectations.
Patricia C. Kienle, RPh, MPA, BCSCP, FASHP, director of accreditation and medication safety for Cardinal Health, brings her expertise to help pharmacy identify gaps to achieving USP <800> compliance. In this webinar, Patti will share tips on establishing policies & procedures, how to conduct an assessment of risk, how to define the role of the Designated Person, and more.
Mark Stanfield, BFA, PharmD, Oncology Pharmacy Specialist at Providence Hood River Cancer Center in Hood River, OR, shares his unique personal story of standing up for the safety of his health system’s patients as well as his own. After receiving a cancer diagnosis, Mark led an effort to update his acute care hospital’s closed system drug-transfer device (CSTD). In this webinar, he will outline the necessary steps to convert to a safer system, discussing the system’s benefits and advantages and providing pointers on how other pharmacies can gain buy-in and exercise influence, regardless of hospital bed size.
Partnering with a 503B outsourced compounder is essential for many hospital pharmacies, but there are a variety of factors to weigh before making a decision. In this webinar, Eric S. Kastango, MBA, RPh, FASHP, vice president and managing partner at Kastango Consulting, provides guidance to the pharmacy, including how to respond to FDA 483s, and what to look for when visiting an outsourced compounding facility, the effects of drug shortages, and more.
With the COVID-19 pandemic, pharmacy must manage new challenges in medication handling, including risks related to product selection, preparation, and administration. In this webinar, Rob Accetta, RPh, BCGP, C-MTM, will explore how to improve communication among all members of the health care team under today’s circumstances and beyond for safer patient outcomes. The presentation will explore solutions to some of the clinical and practical challenges in medication handling, with a focus on compounding and medication crushing. Attendees will learn about an FDA-approved product that provides a safe alternative when clinically appropriate.
Jeffrey Swanson, head of sales at Pharma Logistics, outlines how pharmacists can help prevent opioid abuse and overdose. In an effort to prevent diversion and misuse of opioid prescriptions, attendees will learn: How to identify signs that a patient may be struggling with opioid use disorder; Best practices for working collaboratively with prescribers; How to counsel patients suspected of opioid use disorder; Safe disposal methods for unused opioids.
Bhavesh Shah, RPh, BCOP, director of specialty and hematology/oncology services at Boston Medical Center, discusses his hospital’s experience implementing a new cleanroom amidst the COVID-19 crisis. Topics such as financing, certification, and emergency considerations are examined, providing useful tips for facilities to use during and following the pandemic.
Fred Massoomi, PharmD, FASHP, demonstrates how cleaning fundamentals relate to USP standards for cleaning primary engineering controls (PECs). He will review the fundamentals of effective cleanroom cleaning practices, dispelling myths about compliant cleaning. Participants will also learn how to troubleshoot cleaning programs.
In this webinar, Lou Diorio shares insight into the value of outsourced compounding, how to vet providers, and how this practice can help pharmacy prepare for drug shortages.
Jim Wagner addresses how to work with a certifier, typical issues that arise during the certification process, how to respond to the certification report, and what follow-up measures should be taken.
Mattias Paulsson, deputy chief pharmacist at the Uppsala University Children’s Hospital in Sweden, discusses the advantages of compounding hazardous drugs via robot technology, with a focus on staff and medication safety, cost savings, and workflow efficiency. In addition, training and quality assurance requirements are addressed.
Sarah Emanuele, PharmD, manager of pharmacy systems and operations at the University of Wisconsin, shares her experience leveraging IV workflow software to monitor staff practices in the cleanroom, from garbing to environmental monitoring and cleaning.
Fred Massoomi, PharmD, FASHP, reviews staffing considerations under USP <800>, including topics such as the value of didactic and experiential training and how to establish training by position.
Jim Wagner reviews the impact of the changes to USP <797> with regard to PEC implementation & USP <800> requirements for containment, best positioning of PECs for improving workflow, and provides important insight into airflow considerations.
Kevin Hansen lists considerations for insourcing RTA syringes with IV robotics, outlines an implementation strategy for IV robotic insourcing, and interprets compounding standards to appropriately apply extended beyond-use dates to compounded sterile preparations.
Mike Broyles, BS Pharm, PharmD addresses procalcitonin aided antibiotic stewardship, and reviewing current biomarkers used in the management of bacterial infection.
Dennis Killian reviews considerations for insourcing RTA syringes with IV robotics, demonstrates how one facility evaluated and implemented insourcing RTA syringes with IV robotics, and discusses strategies to optimize an IV robotics sterile compounding program.
Bryan Prince reviews the timeline for USP <795> compliance, QC processes for nonsterile compounding, staff training steps, and more.
Fred Massoomi outlines how to establish standard operating procedures (SOPs) for cleaning PECs, the level of detail required for these SOPs, and staff training requirements.
Learn the necessary elements to establish a cleanroom layout under USP <800>. Topics include door and pass-through placement, hood and refrigerator placement, air pressure relationships between the buffer room and ante-room locations, and more.
Kevin Hansen shares his approach for developing effective IV preparation and administration strategies that focuses on identifying the most appropriate admixture options and safe compounding practices.
Bryan Prince, aims to help attendees weigh the options of new construction versus remodeling, and other dilemmas that may be facing hospital pharmacies preparing for the December 1, 2019 deadline.
Bryan Prince reviews key design factors, negative pressure risks, and C-PEC considerations, such as filtration, exhaust, and the impact of C-PECs on air change requirements.
Mike Broyles, PharmD, covers the role of procalcitonin as a biomarker for use in antibiotic stewardship.
In this webinar, learn to prepare for cleanroom construction under USP <800>. Topics include HVAC and ventilation requirements, strategies for communicating with engineers and facilities departments, and design tips.
Jim Wagner, President of Controlled Environment Consulting, presents the fourth in our series for planning compliance to USP <800>.
Jim Wagner, President of Controlled Environment Consulting, presents the third in our series for planning compliance to USP <800>.
Jim Wagner, President of Controlled Environment Consulting, presents the second in our series for planning compliance to USP <800>.
Jim Wagner, President of Controlled Environment Consulting, provides guidance on CPEC choices, exhaust requirements, and filtration options in planning compliance to USP <800>.